What is the potential of an invention in the biomedical field? It is possible to patent genetic sequences or stem cells? The patent in the biomedical field is now one of the most debated topics, both from an ethical point of view and for its technical-legal complexity.
Biotecnomed, manager of the cluster of Innovation Health Technologies and District Health, is therefore organising a workshop totally dedicated to biomedical patents. The seminar, organised in collaboration with Bugnion, an important Italian and European company consulting in industrial and intellectual property, is expected to take place on 20th April next at 9:30 in classroom G4 level 0 at the Catanzaro Magna Graecia University.
After a welcome from the President of Biotecnomed, Giovanni Cuda, Sonia Garieri will outline the services on Intellectual Property that Biotecnomed can offer companies and researchers.
This will be followed by a talk from Michela Errico, Bugnion Spa European Patents Consultant, that will address the delicate issue of the patentability of solutions in the medical field and in particular will analyse the advantages and critical issues related to protection in the chemical-biotech industry, for example stem cells, antibodies, genetic-protein sequences, etc.
The workshop is targeting researchers, graduates, entrepreneurs and inventors in the biomedical field who have an idea or a research result they would like to capitalise on.
On the margins of the seminar, anyone who is interested in learning the real potential of their idea can book a one-to-one meeting with the experts and speakers.